Browsing by Subject "Parkinsonian Disorders"
Now showing items 1-5 of 5
-
Fahr's syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases
(2021)Introduction: Fahr's syndrome due to hypoparathyroidism refers to bilateral basal ganglia (BG) calcifications and manifests with movement disorders, seizures, cognitive and behavioral symptoms. Case presentation: We report ... -
Neurodegeneration and inflammation—an interesting interplay in parkinson’s disease
(2020)Parkinson’s disease (PD) is a neurodegenerative disorder, caused by, so far, unknown pathogenetic mechanisms. There is no doubt that pro-inflammatory immune-mediated mechanisms are pivotal to the pathogenicity and progression ... -
Plasma Glutathione and Prodromal Parkinson's Disease Probability
(2022)Background: A decrease in glutathione (GSH) levels is considered one of the earliest biochemical changes in Parkinson's disease (PD). Objective: The authors explored the potential role of plasma GSH as a risk/susceptibility ... -
Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
(2021)The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), ... -
α-Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism
(2021)[No abstract available]